 Human cytomegalovirus CMV infection is a major cause of morbidity and mortality for recipients of allogeneic hematopoietic stem cell transplantationHSCT. we propose to study the immunologic and virologic effects of donor derived CMV specific cytotoxic T lymphocyte CMV-CTL given to transplant recipients 